[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 3, Issue 4 (12-2001) ::
2001, 3(4): 233-238 Back to browse issues page
Does treatment of hyperthyroidism affect serum lipids, lipoproteins and paraoxonase enzyme activity?
M Solati , F Raiszadeh , A Etemadi , F Azizi
Abstract:   (43143 Views)
Abstract: Thyroid hormones play an important role in the synthesis, metabolism, and catabolism of lipids. Hyperthyroid patients have increased susceptibility to oxidative stresses and thus undergo LDL oxidation. Paraoxonase is an HDL-linked enzyme which, in vitro, prevents LDL oxidation and might have an anti-atherogenic effect. The purpose of this study was to compare paraoxonase activity and lipid status before and after treatment of hyperthyroidism. 24 hyperthyroid patients and 23 control subjects were studied. In all subjects after obtaining history and anthropometric measurements, serum levels of thyroid hormones, lipids, lipoproteins, and apolipoproteins and serum paraoxonase activity were measured in a fasting blood sample. All patients were treated with methimazole and followed up for 7.3±3.9 months. Of 24 patients, 15 attained euthyroidism. There were no significant changes in weight, body mass index, and waist to hip ratio after treatment. There was significant decrease in serum levels of T4 (8.4±2.2 vs. 16.6±4.4 µg/dL, P<0.001), T3 (134±38 vs. 250±90 ng/dL, P<0.05), and increase in serum TSH (1.9±2.2 vs. 0.06±0.06 µU/mL, P<0.001). Serum paraoxonase activity significantly increased after treatment (49.0±22.8 vs. 64.6±37.8 IU/mL, P<0.001). Also, treatment caused significant increase in serum cholesterol, triglycerides, LDL-C, cholesterol to HDL and LDL to HDL ratios. HDL and apolipoproteins A-I and B levels did not change following treatment. The observed changes in serum paraoxonase activity in the present study, suggest that the enhanced oxidation observed in these patients can be, at least to some extent, caused by reduced paraoxonase activity.
Keywords: Paraoxonase, Hyperthyroidism, Lipoprotein, Apolipoprotein, Methimazole.
Full-Text [PDF 278 kb]   (3212 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2006/11/21 | Published: 2001/12/15
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Solati M, Raiszadeh F, Etemadi A, Azizi F. Does treatment of hyperthyroidism affect serum lipids, lipoproteins and paraoxonase enzyme activity?. Iranian Journal of Endocrinology and Metabolism 2001; 3 (4) :233-238
URL: http://ijem.sbmu.ac.ir/article-1-163-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3, Issue 4 (12-2001) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4657